Health
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma – News-Medical.Net
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors…
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects.
Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively…
-
Noosa News19 hours agoBrisbane flights cancelled as severe weather set to lash coast
-
Business23 hours agoWhat could happen to the big 4 banks in FY26?
-
Business20 hours ago2 ASX ETFs to benefit from the resurgence of AI
-
Noosa News15 hours agoFormer Brisbane Lions sponsor goes bust, leaving 200 workers in limbo